FRAX-based assessment and intervention thresholds—an exploration of thresholds in women aged 50 years and older in the UK

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Osteoporosis International

• Publication date

  2015-06-16

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s00198-015-3176-0PMID 26077380
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• [Revised osteoporosis diagnostic criteria and Japanese practice guideline on osteoporosis].

  2014cited by this paper
• Diagnosis and management of osteoporosis in postmenopausal women and older men in the UK: National Osteoporosis Guideline Group (NOGG) update 2013.

  2013cited by this paper
• FRAX-based intervention and assessment thresholds for osteoporosis in Romania

  2013cited by this paper
• Sri Lankan FRAX model and country-specific intervention thresholds

  2013cited by this paper
• Comparison of the proportion of patients potentially treated with an anti-osteoporotic drug using the current criteria of the Belgian national social security and the new suggested FRAX® criteria

  2013cited by this paper
• Derivation and validation of updated QFracture algorithm to predict risk of osteoporotic fracture in primary care in the United Kingdom: prospective open cohort study

  2012cited by this paper
• The potential impact of the National Osteoporosis Foundation guidance on treatment eligibility in the USA: an update in NHANES 2005–2008

  2012cited by this paper
• A comparison of case-finding strategies in the UK for the management of hip fractures

  2012influential reference
• 2012 update of French guidelines for the pharmacological treatment of postmenopausal osteoporosis.

  2012cited by this paper
• The impact of a FRAX-based intervention threshold in Turkey: the FRAX-TURK study

  2012cited by this paper
• A framework for the development of guidelines for the management of glucocorticoid-induced osteoporosis

  2012influential reference
• The cost-effectiveness of risedronate in the UK for the management of osteoporosis using the FRAX®

  2010cited by this paper
• Guidelines for the diagnosis and management of osteoporosis in postmenopausal women and men from the age of 50 years in the UK.

  2009cited by this paper
• The potential impact of new National Osteoporosis Foundation guidance on treatment patterns

  2009cited by this paper
• Implications of absolute fracture risk assessment for osteoporosis practice guidelines in the USA

  2008cited by this paper
• FRAX™ and the assessment of fracture probability in men and women from the UK

  2008cited by this paper
• European guidance for the diagnosis and management of osteoporosis in postmenopausal women

  2008cited by this paper
• Case finding for the management of osteoporosis with FRAX®—assessment and intervention thresholds for the UK

  2008cited by this paper
• European guidance for the diagnosis and management of osteoporosis in postmenopausal women

  2008influential reference
• Optimization of BMD Measurements to Identify High Risk Groups for Treatment—A Test Analysis

  2004cited by this paper

• Advancing care: optimizing osteoporosis treatment in the older and oldest old population

  2025cites this paper
• A surrogate FRAX model for Mongolia

  2025cites this paper
• The 2024 UK clinical guideline for the prevention and treatment of osteoporosis

  2025cites this paper
• Cost-effectiveness intervention thresholds for romosozumab and teriparatide in the treatment of osteoporosis in the UK

  2024cites this paper
• Osteoporose – Definition, Risikoerfassung, Diagnose, Prävention und Therapie (Update 2024)

  2024cites this paper
• Update on fracture risk assessment in osteoporosis

  2024cites this paper
• Examining treatment targets and equity in bone-active medication use within secondary fracture prevention: a systematic review and meta-analysis

  2024cites this paper
• Understanding Osteoporosis: Pathophysiology, Risk Factors, Diagnosis, and Management

  2024cites this paper
• Evidence-Based Guideline for the management of osteoporosis in men

  2024cites this paper
• The implications of competing risks and direct treatment disutility in cardiovascular disease and osteoporotic fracture: risk prediction and cost effectiveness analysis.

  2024cites this paper
• Assessing and managing bone health and fracture risk in Parkinson’s disease: the BONE PARK 2 protocol

  2024cites this paper
• FRAX-based intervention thresholds for men in the Russian Federation: Expert consensus of the Russian association on osteoporosis

  2023cites this paper
• First-line immunosuppression in neuromuscular diseases

  2023cites this paper
• Bone health and menopause: Osteoporosis prevention and treatment.

  2023cites this paper
• Asia-pacific consensus on osteoporotic fracture prevention in postmenopausal women with low bone mass or osteoporosis but no fragility fractures.

  2023cites this paper
• An overview of the use of the fracture risk assessment tool (FRAX) in osteoporosis

  2023cites this paper
• Refinement of the osteoporotic fracture risk categorization

  2023cites this paper
• High and extremely high risk of osteoporotic fractures in Chilean women

  2023cites this paper
• Eficacia clínica de los umbrales de intervención híbridos y dependientes de la edad basados en FRAX ® en la población ecuatoriana

  2022cites this paper
• Is it time to consider population screening for fracture risk in postmenopausal women? A position paper from the International Osteoporosis Foundation Epidemiology/Quality of Life Working Group

  2022cites this paper
• Management of patients at very high risk of osteoporotic fractures through sequential treatments

  2022cites this paper
• Trabecular Bone Score Adjustment for the Fracture Risk Assessment Tool (FRAX®)

  2022cites this paper
• Osteoporosis in 2022: Care gaps to screening and personalised medicine

  2022cites this paper
• An assessment of intervention thresholds for high fracture risk in Chile

  2022influential citation
• Osteoporosis treatment in Austria—assessment of FRAX-based intervention thresholds for high and very high fracture risk

  2022cites this paper
• Appropriate FRAX® Intervention Threshold for Pharmacological Treatment of Osteoporosis in Thailand

  2022cites this paper
• Definition and management of very high fracture risk in women with postmenopausal osteoporosis: a position statement from the Brazilian Society of Endocrinology and Metabolism (SBEM) and the Brazilian Association of Bone Assessment and Metabolism (ABRASSO)

  2022cites this paper
• Clinical efficacy of FRAX ® -based hybrid and age-dependent intervention thresholds in the Ecuadorian population

  2022cites this paper
• UK clinical guideline for the prevention and treatment of osteoporosis

  2022cites this paper
• Fracture risk assessment by the FRAX model

  2021cites this paper
• A comparison of fracture risk assessment tools

  2021cites this paper
• Development of the Asia Pacific Consortium on Osteoporosis (APCO) Framework: clinical standards of care for the screening, diagnosis, and management of osteoporosis in the Asia-Pacific region

  2021cites this paper
• Impact of population-based or targeted BMD interventions on fracture incidence

  2021cites this paper
• An assessment of intervention thresholds for very high fracture risk applied to the NOGG guidelines

  2021influential citation
• FRAX-based osteoporosis treatment guidelines for resource-poor settings in India

  2021cites this paper
• Long-Term Treatment of Postmenopausal Osteoporosis

  2021cites this paper
• Treatment indications and thresholds of intervention: consensus and controversies in osteoporosis

  2021cites this paper
• Update on bone health: the International Menopause Society White Paper 2021

  2021cites this paper
• The application of FRAX in Ecuador

  2021cites this paper
• Osteoporosis case ascertainment strategies in European and Asian countries: a comparative review

  2020cites this paper
• The Belgian Bone Club 2020 guidelines for the management of osteoporosis in postmenopausal women.

  2020influential citation
• Targeted bone density testing for optimizing fracture prevention in Canada

  2020cites this paper
• A decade of FRAX: how has it changed the management of osteoporosis?

  2020cites this paper
• Defining Very High Fracture Risk: Is FRAX Fit for Purpose?

  2020cites this paper
• Osteoporosis in the Oldest Old

  2019cites this paper
• Algorithm for the management of patients at low, high and very high risk of osteoporotic fractures

  2019cites this paper
• Novel algorithm generating strategy to identify high fracture risk population using a hybrid intervention threshold

  2019cites this paper
• The ten-year probability of fractures with the FRAX tool: which threshold for intervention to be used and how?

  2019cites this paper
• Use of oral bisphosphonates and risk of hospital admission with osteonecrosis of the jaw: Large prospective cohort study in UK women.

  2019cites this paper
• Management of fracture risk in Parkinson's: A revised algorithm and focused review of treatments.

  2019cites this paper
• Revised FRAX®-based intervention thresholds for the management of osteoporosis among postmenopausal women in Sri Lanka

  2019cites this paper
• Comparison of treatment strategies and thresholds for optimizing fracture prevention in Canada: a simulation analysis

  2019cites this paper
• Underestimated fracture risk in postmenopausal women—application of the hybrid intervention threshold

  2019cites this paper
• European guidance for the diagnosis and management of osteoporosis in postmenopausal women

  2018cites this paper
• An Update on Menopause ManagementSymbol

  2018cites this paper
• FRAX® based intervention thresholds for management of osteoporosis in Singaporean women

  2018cites this paper
• Cost-effective but clinically inappropriate: new NICE intervention thresholds in osteoporosis (Technology Appraisal 464)

  2018cites this paper
• NOGG and NICE: New guidelines and quality standards for osteoporosis.

  2017cites this paper
• UK clinical guideline for the prevention and treatment of osteoporosis

  2017cites this paper
• Worldwide Fracture Prediction.

  2017cites this paper
• Is drug-induced bone loss acceptable in premenopausal women? A practical fracture risk modeling exercise

  2017cites this paper
• A szakellátásban megjelenő osteoporosisos nők 10 éves csonttöréskockázata a FR AX ® alapján Ten-year fracture risk by FRAX ® of women with osteoporosis attending osteoporosis care in Hungary

  2016cites this paper
• A systematic review of intervention thresholds based on FRAX

  2016influential citation
• [Ten-year fracture risk by FRAX(®) of women with osteoporosis attending osteoporosis care in Hungary].

  2016cites this paper
• The FRAX-based Lebanese osteoporosis treatment guidelines: rationale for a hybrid model

  2016cites this paper
• Age-related fragility fracture: insights from the natural homeostatic system in the skeleton

  2015cites this paper
• Osteoporose-Update 2015

  2015cites this paper
• A BRIEF PRESENTATION OF ANTIPHOSPHOLIPID ANTIBODIES AND THE PREGNANCY OUTCOME AFTER THERAPY

  2015cites this paper
• Ostéoporose – mise à jour

  2015cites this paper
• High and very high risk of osteoporotic fractures in Chilean women

  year unknowncites this paper
• Asia e pacific consensus on osteoporotic fracture prevention in postmenopausal women with low bone mass or osteoporosis but no fragility fractures

  year unknowncites this paper